Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(12 sites)

Argentina

Fundación Huésped, Buenos Aires

Brazil

Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte

Evandro Chagas National Institute of Infectious Diseases-Oswaldo Cruz Foundation-FIOCRUZ, Rio de Janeiro

Federal Hospital for State Employees, Rio de Janeiro

Nova Iguaçu General Hospital, Rio de Janeiro

University Hospital Prof. Edgard Santos, Salvador

Emílio Ribas Institute of Infectious Diseases, São Paulo

STD/AIDS Reference and Training Center, São Paulo

Switzerland

Hôpitaux Universitaires de Genève, Geneva, Canton of Geneva

Pr Alexandra Calmy, Geneva, Canton of Geneva

CHUV, Lausanne, Canton of Vaud

Zürich checkpoint, Zurich, Canton of Zurich